Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease Clinical Trials in Wuhan, Hubei
2 recruitingWuhan, Hubei, China
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
Myasthenia GravisAutoimmune EncephalitisMultiple Sclerosis+7 more
Tongji Hospital36 enrolled1 locationNCT04561557
Recruiting
Not Applicable
Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
Multiple SclerosisAcute Disseminated EncephalomyelitisNeuromyelitis Optica Spectrum Disorder+2 more
Tongji Hospital250 enrolled1 locationNCT06474520